Abner Herrman & Brock Has Raised Johnson & Johnson (JNJ) Position; Shelton Capital Management Trimmed By $714,000 Its Metlife (MET) Position

Shelton Capital Management decreased Metlife Inc (MET) stake by 13.96% reported in 2017Q3 SEC filing. Shelton Capital Management sold 14,000 shares as Metlife Inc (MET)’s stock declined 4.70%. The Shelton Capital Management holds 86,257 shares with $4.48 million value, down from 100,257 last quarter. Metlife Inc now has $54.55 billion valuation. The stock increased 0.93% or $0.48 during the last trading session, reaching $51.84. About 3.42M shares traded. MetLife, Inc. (NYSE:MET) has risen 13.92% since January 6, 2017 and is uptrending. It has underperformed by 2.78% the S&P500.

Abner Herrman & Brock Llc increased Johnson & Johnson (JNJ) stake by 12.86% reported in 2017Q3 SEC filing. Abner Herrman & Brock Llc acquired 3,240 shares as Johnson & Johnson (JNJ)’s stock rose 6.85%. The Abner Herrman & Brock Llc holds 28,437 shares with $3.70 million value, up from 25,197 last quarter. Johnson & Johnson now has $380.71 billion valuation. The stock increased 0.83% or $1.16 during the last trading session, reaching $141.71. About 6.16M shares traded or 14.52% up from the average. Johnson & Johnson (NYSE:JNJ) has risen 12.54% since January 6, 2017 and is uptrending. It has underperformed by 4.16% the S&P500.

Shelton Capital Management increased Morgan Stanley (NYSE:MS) stake by 58,545 shares to 174,424 valued at $8.40 million in 2017Q3. It also upped Kellogg Co (NYSE:K) stake by 54,500 shares and now owns 301,416 shares. New York Cmnty Bancorp Inc (NYSE:NYCB) was raised too.

Among 16 analysts covering MetLife (NYSE:MET), 9 have Buy rating, 1 Sell and 6 Hold. Therefore 56% are positive. MetLife has $7800 highest and $46 lowest target. $58.75’s average target is 13.33% above currents $51.84 stock price. MetLife had 46 analyst reports since July 31, 2015 according to SRatingsIntel. The rating was maintained by Morgan Stanley with “Equal-Weight” on Thursday, October 5. On Tuesday, January 5 the stock rating was downgraded by Citigroup to “Neutral”. The company was maintained on Monday, July 10 by Wells Fargo. On Monday, June 5 the stock rating was maintained by RBC Capital Markets with “Buy”. On Wednesday, August 2 the stock rating was maintained by Wells Fargo with “Buy”. The stock has “Outperform” rating by FBR Capital on Thursday, May 25. The company was downgraded on Wednesday, July 13 by Deutsche Bank. The stock of MetLife, Inc. (NYSE:MET) earned “Outperform” rating by Macquarie Research on Thursday, January 14. On Monday, July 24 the stock rating was initiated by J.P. Morgan with “Hold”. The stock of MetLife, Inc. (NYSE:MET) earned “Hold” rating by Sandler O’Neill on Friday, November 10.

Investors sentiment decreased to 0.89 in Q3 2017. Its down 0.05, from 0.94 in 2017Q2. It dropped, as 61 investors sold MET shares while 336 reduced holdings. 65 funds opened positions while 289 raised stakes. 784.85 million shares or 1.65% more from 772.09 million shares in 2017Q2 were reported. Security National Trust Company holds 0.23% in MetLife, Inc. (NYSE:MET) or 13,445 shares. Pennsylvania Co reported 36,712 shares. Cornerstone Investment Ptnrs Ltd Co stated it has 0.05% in MetLife, Inc. (NYSE:MET). Nippon Life Glob Invsts Americas stated it has 0.82% of its portfolio in MetLife, Inc. (NYSE:MET). Hall Laurie J Trustee stated it has 535 shares. Commerzbank Aktiengesellschaft Fi has invested 0.08% of its portfolio in MetLife, Inc. (NYSE:MET). Univest Of Pennsylvania stated it has 0.22% of its portfolio in MetLife, Inc. (NYSE:MET). Royal Comml Bank Of Canada invested 0.04% in MetLife, Inc. (NYSE:MET). Lpl Fincl Ltd Liability holds 0.03% or 155,649 shares in its portfolio. Bessemer reported 20,864 shares. Arizona State Retirement System holds 0.19% in MetLife, Inc. (NYSE:MET) or 303,896 shares. Alpha Windward Ltd Liability accumulated 0.11% or 3,321 shares. Bowen Hanes And owns 25,595 shares or 0.06% of their US portfolio. Buckingham Asset Ltd Com owns 4,457 shares. Duncker Streett Comm invested 0.2% in MetLife, Inc. (NYSE:MET).

Analysts await MetLife, Inc. (NYSE:MET) to report earnings on February, 7. They expect $1.11 earnings per share, down 17.78% or $0.24 from last year’s $1.35 per share. MET’s profit will be $1.17B for 11.68 P/E if the $1.11 EPS becomes a reality. After $1.09 actual earnings per share reported by MetLife, Inc. for the previous quarter, Wall Street now forecasts 1.83% EPS growth.

Investors sentiment is 0.83 in Q3 2017. Its the same as in 2017Q2. It is without change, as 45 investors sold JNJ shares while 871 reduced holdings. only 111 funds opened positions while 645 raised stakes. 1.71 billion shares or 0.90% less from 1.73 billion shares in 2017Q2 were reported. First Light Asset Mgmt stated it has 0.09% in Johnson & Johnson (NYSE:JNJ). Tukman Grossman Capital Mngmt invested in 8.11% or 83,038 shares. Compass Cap has 3.83% invested in Johnson & Johnson (NYSE:JNJ) for 185,499 shares. Westwood Mgmt Il has 4,850 shares for 0.09% of their portfolio. M&T Fincl Bank Corporation reported 2.48 million shares. Tirschwell & Loewy Inc owns 199,183 shares or 3.92% of their US portfolio. Lederer And Associates Counsel Ca invested in 2.5% or 20,187 shares. Ig Investment Mngmt Ltd reported 1.25% in Johnson & Johnson (NYSE:JNJ). 205,081 are owned by Cullen Frost Bankers. Union National Bank & Trust Corporation reported 2.38% stake. 118,660 were reported by American Secs Inc (D B A Uas Asset Management). 88,175 were reported by Wallington Asset Mgmt Ltd Liability Corporation. Omers Administration reported 0.86% in Johnson & Johnson (NYSE:JNJ). Ci Invests has 0.28% invested in Johnson & Johnson (NYSE:JNJ) for 234,227 shares. Citizens And Northern Corp holds 0.86% or 8,719 shares.

Among 23 analysts covering Johnson & Johnson (NYSE:JNJ), 12 have Buy rating, 5 Sell and 6 Hold. Therefore 52% are positive. Johnson & Johnson has $165 highest and $90 lowest target. $136.94’s average target is -3.37% below currents $141.71 stock price. Johnson & Johnson had 84 analyst reports since August 7, 2015 according to SRatingsIntel. Cowen & Co maintained Johnson & Johnson (NYSE:JNJ) rating on Thursday, August 24. Cowen & Co has “Buy” rating and $147.0 target. The firm has “Buy” rating by Citigroup given on Monday, October 23. The rating was maintained by RBC Capital Markets on Sunday, August 27 with “Buy”. The company was initiated on Monday, September 25 by Citigroup. As per Wednesday, October 7, the company rating was maintained by RBC Capital Markets. Cowen & Co maintained Johnson & Johnson (NYSE:JNJ) on Tuesday, August 25 with “Outperform” rating. The stock of Johnson & Johnson (NYSE:JNJ) earned “Buy” rating by Deutsche Bank on Tuesday, September 29. UBS initiated Johnson & Johnson (NYSE:JNJ) on Tuesday, September 22 with “Buy” rating. The company was maintained on Friday, September 22 by RBC Capital Markets. The rating was maintained by Jefferies with “Hold” on Tuesday, August 15.